reader Posted November 16, 2021 Share Posted November 16, 2021 From Channel News Asia KUALA LUMPUR: Malaysia is aspiring to become the hepatitis C treatment hub for Asia, with promises of treatment at a fraction of current costs. Health Minister Khairy Jamaluddin said that Malaysia is poised to offer affordable and efficacious treatments for those infected with the virus. This is made possible as Malaysia is the first country in the world to be given conditional approval for the use of Ravidasvir in combination with Sofosbuvir to treat hepatitis C. “I hope Malaysia, launched today as a destination for Hep C treatment will offer those suffering from this disease access to more effective, accessible, and crucially more affordable solutions,” Mr Khairy said in a keynote address at a medical travel conference on Tuesday (Nov 16). A 12-week cost of treatment for hepatitis which in Malaysia could come up to RM356,000 (US$84,000), a factor that prohibits many from seeking treatment. Health Ministry director-general Dr Noor Hisham Abdullah had said previously that it is possible to get a 12-week treatment using Ravidasvir and a generic version of Sofosbuvir at a cost of US$100 by getting it produced locally. The hepatitis C virus, which is transmitted through blood, can cause liver cirrhosis, scarring and cancer if untreated. https://www.channelnewsasia.com/asia/malaysia-hepatitis-c-medical-tourism-2316876 Quote Link to comment Share on other sites More sharing options...
